Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Realeve
AddedFeb 15, 2024
UpdatedJun 18, 2026
Realeve

Realeve

Late Stage Private

Realeve: Innovating miniaturized neurostimulation devices for advanced headache treatment.

HQ
Mountain View, CA, US
Founded
2007
Overview
Compare
Fundraising
Employees

Realeve's core mission is to revolutionize headache treatment through advanced neurostimulation technology. The company focuses on developing miniaturized neurostimulation devices aimed at providing effective relief for severe headaches. Their innovative products target a niche market of patients seeking advanced medical solutions for chronic headache conditions.

Realeve has made significant strides in the medical device industry, setting new standards for headache treatment. Their cutting-edge technology has garnered attention for its potential to improve patient outcomes. The company's impactful work in neurostimulation highlights its commitment to advancing healthcare solutions.

Realeve - Similar Companies

Epic Neuro logo

Epic Neuro

Scion Neurostim logo

Scion Neurostim

scionneurostim.com

Nexeon Medsystems logo

Nexeon Medsystems

nexeonmed.com

ShiraTronics logo

ShiraTronics

shiratronics.com

Niche Biomedical logo

Niche Biomedical

Micro-Leads logo

Micro-Leads

NeuraLace Medical logo

NeuraLace Medical

electroCore logo

electroCore

Auricle logo

Auricle

auricle.com

Nevro logo

Nevro

Cervel Neurotech logo

Cervel Neurotech

cervel.com

Attune Neurosciences logo

Attune Neurosciences

attuneneuro.com

Relievant Medsystems logo

Relievant Medsystems

relievant.com

Revelhmi logo

Revelhmi

Nia Therapeutics logo

Nia Therapeutics

Realeve - Quick Facts

Who are Realeve's competitors?

Companies similar to Realeve include Epic Neuro, Scion Neurostim, Nexeon Medsystems and ShiraTronics.

When was Realeve founded?

Realeve was founded in 2007.

Where is Realeve's headquarters located?

Realeve's headquarters is located in Mountain View, CA, US.

How much has Realeve raised to-date?

As of Jan 1, 2016, Realeve has raised a total of $136.2M (USD).

How many employees does Realeve have?

Realeve has 30 employees as of Feb 4, 2024.

Realeve - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Neurostimulation
Geographic Exposure
  • Americas
Revenue
  • Recurring
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified